Daniel Engelbertsen (D Engelbertsen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Cardiovascular research

Scientific reports

Lunds Universitet

Lund University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lunds Universitet

Sweden

Assistant Researcher

Brigham and Women's Hospital

United States

Postdoctoral Fellow :: Department of Pathology

Education History

Lund University Jun 01 2009 - May 17 2013

Sweden

PHD :: Department of Clinical Sciences, Malmö

Lund University Sep 01 2005 - Jun 01 2009

Sweden

MSC

Publications

Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular research 120 (6) (2024)
Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular research (2024)
Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular research 120 (6) (2024)
Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular research 120 (6) (2024)
Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular research 120 (6) (2024)
J Vallejo, P Dunér, F To, Daniel Engelbertsen, I Gonçalves, Jan Nillson, E Bengtsson
Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice. Scientific reports 9 (1) (2019)
Daniel Engelbertsen, Anu Autio, Robin A F Verwilligen, Marie A C Depuydt, Gail Newton, Sara Rattik, Erik Levinsohn, Gurpanna Saggu, Petr Jarolim, Huan Wang, Francisco Velazquez, Andrew H Lichtman, Francis W Luscinskas
Increased lymphocyte activation and atherosclerosis in CD47-deficient mice. Scientific reports 9 (1) (2019)

Daniel Engelbertsen.css-eqlu8i{font-size:small;padding-left:4px;} (D Engelbertsen)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Engelbertsen (D Engelbertsen)